James Healy, M.D., Ph.D.

James Healy, M.D., Ph.D.

DirectoratArriVent BioPharma· In proxies 2024–2025

James Healy, M.D., Ph.D. is Director of ArriVent BioPharma.

Experience

  1. ArriVent BioPharmaPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role -21%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?